TY - JOUR
T1 - Discontinuation of outpatient medications
T2 - implications for electronic messaging to pharmacies using CancelRx
AU - Pitts, Samantha I.
AU - Yang, Yushi
AU - Thomas, Bridgette
AU - Chen, Allen R.
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved.
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Electronic communication of prescription discontinuation, or CancelRx, has the potential to improve medication safety. We aimed to describe the proportion of discontinued outpatient medications that would result in a CancelRx message to understand its impact on medication safety. We used a data report to identify all outpatient medications discontinued in the electronic health record (EHR) of an academic health system in 1 month (October 2018). Among all 63485 medications discontinued, 23118 (36.4%) were e-prescribed, 25982 (40.9%) were patient-reported or reconciled, and the remainder prescribed nonelectronically. Discontinued high-risk medications were more likely to be e-prescribed (2768 of 5896, 47.0%). A discontinuation reason was specified in 37353 (58.9%) of all discontinued medications. Approximately one-third to one-half of discontinued medications were e-prescribed within the same EHR and would result in a CancelRx message to the pharmacy. Extension of this functionality to medications reconciled in the EHR could significantly expand the impact of CancelRx on medication safety. In addition, complete and accurate discontinuation reasons are needed to optimize CancelRx implementation.
AB - Electronic communication of prescription discontinuation, or CancelRx, has the potential to improve medication safety. We aimed to describe the proportion of discontinued outpatient medications that would result in a CancelRx message to understand its impact on medication safety. We used a data report to identify all outpatient medications discontinued in the electronic health record (EHR) of an academic health system in 1 month (October 2018). Among all 63485 medications discontinued, 23118 (36.4%) were e-prescribed, 25982 (40.9%) were patient-reported or reconciled, and the remainder prescribed nonelectronically. Discontinued high-risk medications were more likely to be e-prescribed (2768 of 5896, 47.0%). A discontinuation reason was specified in 37353 (58.9%) of all discontinued medications. Approximately one-third to one-half of discontinued medications were e-prescribed within the same EHR and would result in a CancelRx message to the pharmacy. Extension of this functionality to medications reconciled in the EHR could significantly expand the impact of CancelRx on medication safety. In addition, complete and accurate discontinuation reasons are needed to optimize CancelRx implementation.
KW - electronic prescribing
KW - medication reconciliation
KW - patient safety
UR - http://www.scopus.com/inward/record.url?scp=85142401072&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142401072&partnerID=8YFLogxK
U2 - 10.1093/jamia/ocac181
DO - 10.1093/jamia/ocac181
M3 - Article
C2 - 36240449
AN - SCOPUS:85142401072
SN - 1067-5027
VL - 29
SP - 2101
EP - 2104
JO - Journal of the American Medical Informatics Association
JF - Journal of the American Medical Informatics Association
IS - 12
ER -